Pharmaceutical companies are producing testosterone replacement therapies, which are being touted as anti-aging treatments, while the U.S. military tests service members' levels.
Steady: 0 in the last 7 days
Updated sep 23
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pharmaceutical companies are producing testosterone replacement therapies, which are being touted as anti-aging treatments, while the U.S. military tests service members' levels.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.The military is prioritizing testosterone testing over diplomatic solutions.1 source
- The industry surrounding testosterone replacement therapy (TRT) is flourishing, driven by virtual suppliers and the broader market.Sub-event
Pharma companies are making testosterone replacement therapies, and the U.S. military will test service members' levels.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Testosterone
- The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.
- The Pentagon is issuing screening guidelines for low testosterone, linking it to national defense readiness, following discussions involving Brian Christine and Fox News.